On August 4, 2025, Novo Nordisk A/S received an unsolicited mini-tender offer from TRC Capital to buy 2,000,000 of its American Depositary Shares, representing less than 0.045% of its total shares. Novo Nordisk does not endorse this offer and advises shareholders to exercise caution.